Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 424B3 Offering Prospectus
  2. 424B3 Offering Prospectus
  3. 10-Q Report Quarterly Report
  4. ARS Other Annual Report to Security Holders
  5. DEFA14A Proxy Proxy Materials
  6. DEF 14A Proxy Proxy Statement
  7. PRER14A Other PRER14A
  8. PRE 14A Proxy Proxy Statement (Preliminary)
  9. 8-K Event Other events
  10. 424B5 Offering Prospectus
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. 8-K Event Delisting notice · Executive or director change · Other events
  13. 8-K Event Other events
  14. 424B5 Offering Prospectus
  15. 424B3 Offering Prospectus
  16. 424B3 Offering Prospectus
  17. 424B3 Offering Prospectus
  18. 424B3 Offering Prospectus
  19. 10-Q Report Quarterly Report
  20. 8-K Event Other events

Page 2 of 72 · 1,429 filings